Loading asset research
Definium Therapeutics Inc. Common Shares
DFTXNasdaq · USD · StocksQuote as of · Exchange session not verified$38.91
+3.13%
Today
DFTX
Loading 1D prices…
Market cap
$5.2B
Volume
1.8M
52w high
$49.7052w low
$8.77Company profile
Definium Therapeutics Inc. Common Shares
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.
Sector
Health Care
Industry
Medicinal Chemicals & Botanical Products
Exchange
Nasdaq
Display currency
USD
Location
New York, NY, United States
Employees
105
Fiscal year end
1231
CIK
1813814
Session & valuation
Open$37.73
Previous close$37.73
Day high$39.37
Day low$37.73
30-day avg. volume2M
Outstanding shares134.4M
Diluted EPS-$2.06
Latest annual period
P/E (trailing)-18.89
P/E (forward)-20.74
Price / book5.69
Beta2.24
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2833
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| RGCRegencell Bioscience Holdings Limited Ordinary Shares | $2.6B | $0.00 | — | -$0.72 | +0.27% | Unrated |
| TRLVTrulieve Cannabis Corp. Subordinate Voting Shares | $2.2B | $1.2B | -9.85% | -$0.58 | +0.00% | Buy |
| CRONCronos Group Inc. Common Share | $1.2B | $146.6M | -1.98% | -$0.02 | -0.63% | Buy |
| GLASGlass House Brands Inc. Subordinate Voting Shares | $747.3M | $182M | -16.30% | -$0.55 | -0.63% | Buy |
| TLRYTilray Brands Inc. Common Stock | $553.1M | $915.5M | -13.26% | -$1.09 | -3.02% | Hold |